University of California System Warily Eyes GOP Budget Cutting

For much of the past year, policymakers in Congress have focused on Republican plans to slash government spending and balance the federal budget. STRATEGY: UC president Richard C. Atkinson says he plans to continue to "seek the very best people". Whatever the funding levels for fiscal 1996, the Republicans have proposed deep cuts in federal spending for scientific research into the next millennium. Such spending has amounted to roughly $73 billion annually in recent years. But the "Contract W

Written byBruce Bigelow
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Richard Atkins STRATEGY: UC president Richard C. Atkinson says he plans to continue to "seek the very best people".

The academic institution with arguably the greatest stake in the outcome is the University of California (UC) system, which is widely regarded as the flagship of public education in the United States.

How the University of California adjusts to the new reality in federal research funding is also likely to serve as a bellwether for other universities across the country, as the nine-campus system includes some of the nation's premier research universities.

C-L Tien JEOPARDY: Chang-Lin Tien calls the cutbacks "a national security issue."

Federal funding, awarded chiefly through competitive grants and contracts, accounts for roughly 58 percent of all UC research expenditures.

That means the UC system has a lot at risk in the calculus of federal cutbacks, but administrators point out that over the past few decades they have been able to parlay ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies